![Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018 Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018](https://journals.sagepub.com/cms/10.1177/2040620718761778/asset/images/large/10.1177_2040620718761778-fig1.jpeg)
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018
![SocforHemepath on Twitter: "Another new provisional entity in the 2017 WHO: Acute Myeloid Leukemia with BCR-ABL1. This is a type of de novo AML, not to be confused with the blast phase SocforHemepath on Twitter: "Another new provisional entity in the 2017 WHO: Acute Myeloid Leukemia with BCR-ABL1. This is a type of de novo AML, not to be confused with the blast phase](https://pbs.twimg.com/media/D8_lwrCU4AASdy6.jpg)
SocforHemepath on Twitter: "Another new provisional entity in the 2017 WHO: Acute Myeloid Leukemia with BCR-ABL1. This is a type of de novo AML, not to be confused with the blast phase
![Survival of de novo acute myeloid leukemia at MD Anderson (1970-2017)... | Download Scientific Diagram Survival of de novo acute myeloid leukemia at MD Anderson (1970-2017)... | Download Scientific Diagram](https://www.researchgate.net/publication/349513867/figure/fig1/AS:998764483448832@1615135417528/Survival-of-de-novo-acute-myeloid-leukemia-at-MD-Anderson-1970-2017-by-Age-and.png)
Survival of de novo acute myeloid leukemia at MD Anderson (1970-2017)... | Download Scientific Diagram
![Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/5/2917/F1.large.jpg)
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
![Decitabine shows comparable OS to standard induction chemotherapy and better safety in patients with AML Decitabine shows comparable OS to standard induction chemotherapy and better safety in patients with AML](https://aml-hub.com/media/images/89/ec/fig-1.jpg)
Decitabine shows comparable OS to standard induction chemotherapy and better safety in patients with AML
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 | Haematologica
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities | Haematologica
![Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology](https://mp.uscap.org/cms/attachment/0ec8d0a3-2104-40bf-a4d2-33488d312d2d/gr1_lrg.jpg)
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology
![High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-022-00740-3/MediaObjects/41408_2022_740_Fig1_HTML.png)
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal
![Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management | Tasman Medical Journal Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management | Tasman Medical Journal](https://tasmanjournals.com/tmj/files/2020/10/Screen-Shot-2020-10-26-at-10.36.25-AM.png)
Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management | Tasman Medical Journal
![How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube](https://i.ytimg.com/vi/5J3339MOWjU/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLAZrqYr0ig2piwfqIFiYNEwXlUl3g)
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
![A single-cell survey of cellular hierarchy in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text A single-cell survey of cellular hierarchy in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-020-00941-y/MediaObjects/13045_2020_941_Fig2_HTML.png)
A single-cell survey of cellular hierarchy in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
![Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram](https://www.researchgate.net/publication/264291969/figure/fig4/AS:202947481870340@1425397858167/Common-mutations-in-de-novo-and-secondary-AML-A-number-of-clonal-blood-disorders-with-a.png)
Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram
![Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia](https://www.mdpi.com/genes/genes-11-00749/article_deploy/html/images/genes-11-00749-g001-550.jpg)
Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
![Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia](https://www.spandidos-publications.com/article_images/ol/12/1/ol-12-01-0262-g02.jpg)